Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Mar 2 2021

Full Issue

Don't 'Shop' For Specific Vaccine Brand, State Officials Urge

With three shots now available with differing dosing regimens, reported efficacy and availability, health officials worry that Americans will hold out for the one they want -- delaying efforts to quickly vaccinate the nation.

Bloomberg: J&J Covid Vaccine Could Protect Millions—If They Take It

Johnson & Johnson’s Covid-19 vaccine could protect millions more Americans from contracting the coronavirus. The key will be assuring people that the single-shot vaccine is worth taking, as its overall efficacy appears lower than the two-dose ones already on the market in the U.S. J&J’s shot, which U.S. regulators authorized Saturday, is more convenient than the vaccines cleared by the Food and Drug Administration last year. It requires one injection and can be stored for months in a refrigerator. State health officials and the Biden administration see it as a way to quickly host mass clinics as more transmissible virus variants continue to spread. Yet the ease of distributing the vaccine will need to be balanced with the risk of creating the perception that J&J’s shot is an inferior option. (LaVito and Griffin, 3/1)

Boston Globe: State Officials, Community Leaders Try To Dissuade Residents From Vaccine ‘Shopping’

With a third COVID-19 vaccine soon to be available in Massachusetts, state officials and community leaders Monday sought to discourage residents from “shopping” for one brand over another, stressing that all are highly protective against serious disease from the coronavirus. The assurances stemmed from apparent concern the newly authorized Johnson & Johnson vaccine, a one-shot formula officials view as ideal for hard-to-reach populations, might be regarded as an inferior product — especially by marginalized communities distrustful of the health care system. (Weisman, 3/1)

CNN: Which Covid-19 Vaccine Should I Get? Dr. Wen Weighs In 

And then there were three. There are now three Covid-19 vaccines authorized for emergency use by the US Food and Drug Administration, manufactured by Pfizer/BioNTech, Moderna and Johnson & Johnson. All three will be distributed across the United States. Many people are wondering which Covid-19 vaccine they should get: Is one better for certain groups of people? (Hetter, 3/2)

The Hill: New Orleans Archdiocese Calls For Catholics To Avoid Johnson & Johnson Vaccine

The Catholic Archdiocese of New Orleans urged Catholics on Friday against taking a vaccine for COVID-19 manufactured by Johnson & Johnson because the vaccine is developed from stem cells obtained from two abortions. In a statement on the archdiocese's website, the organization argued that Johnson & Johnson's vaccine was "morally compromised." (Bowden, 3/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF